Japanese subpopulation analysis of the RENAAL, the landmark trial, is welcomed by our society.
Kimura
Genjiro
G
D047228:Angiotensin II Type 1 Receptor Blockers / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003924:Diabetes Mellitus, Type 2 / Q000150:complications* / Q000453:epidemiology / Q000208:ethnology; D003928:Diabetic Nephropathies / Q000188:drug therapy* / Q000453:epidemiology / Q000208:ethnology / Q000517:prevention & control; D006801:Humans; D007564:Japan / Q000453:epidemiology / Q000208:ethnology; D007674:Kidney Diseases / Q000188:drug therapy* / Q000453:epidemiology / Q000208:ethnology / Q000517:prevention & control; D007676:Kidney Failure, Chronic / Q000453:epidemiology / Q000503:physiopathology / Q000517:prevention & control; D019808:Losartan / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D012084:Renin-Angiotensin System / Q000187:drug effects / Q000502:physiology
D047228:Angiotensin II Type 1 Receptor Blockers; D019808:Losartan